S2 Genomics specializes in advanced technologies for single-cell genomics, primarily through their innovative Singulator™ Platform. This automated system is designed to streamline the dissociation of solid tissues into high-quality, viable single cells or intact nuclei, significantly reducing the variability associated with manual methods. The Singulator™ Platform is capable of processing a wide range of tissue types, including fresh, frozen, and formalin-fixed paraffin-embedded (FFPE) samples, and can isolate single nuclei in as little as six minutes from minimal input tissue. By employing precise instrumentation and user-friendly software, the platform ensures reproducibility and precision, which are critical for reliable genomic analyses.

The Singulator™ Platform also includes specialized cartridges and reagents that enhance the efficiency and effectiveness of the isolation process. These consumables are designed to minimize sample loss and preserve the integrity of biological material, thereby facilitating high-quality data generation. The system's automated workflow not only saves time but also reduces the potential for human error, making it an invaluable tool for researchers engaged in high-throughput clinical and translational studies. Overall, S2 Genomics' technologies are positioned to advance the field of single-cell genomics by providing reliable, reproducible, and efficient solutions for sample preparation.

United States

S2 Genomics is developing integrated sample preparation systems processing tissues and liquid samples into genomic samples.S2 Genomics is also developing single cell spatial sequencing™technology that will capture the spatial location,i.e., 3-dimensional coordinates, of single cells in tissue for NGS readout.

S2 Genomics

Company Details